{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:54Z","timestamp":1790742054102,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171572"],"award-info":[{"award-number":["82171572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171571"],"award-info":[{"award-number":["82171571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970211"],"award-info":[{"award-number":["81970211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171571"],"award-info":[{"award-number":["82171571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Postdoctoral Innovative Talents Support Progra"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tyrosine phosphorylation by protein tyrosine kinases (PTKs) is a type of post-translational modification. Tec kinases, which are a subfamily of non-receptor PTKs, were originally discovered in the hematopoietic system and include five members: Tec, Btk, Itk\/Emt\/Tsk, Etk\/Bmx, and Txk\/Rlk. With the progression of modern research, certain members of the Tec family of kinases have been found to be expressed outside the hematopoietic system and are involved in the development and progression of a variety of diseases. The role of Tec family kinases in cardiovascular disease is receiving increasing attention. Tec kinases are involved in the occurrence and progression of ischemic heart disease, atherosclerosis, cardiac dysfunction associated with sepsis, atrial fibrillation, myocardial hypertrophy, coronary atherosclerotic heart disease, and myocardial infarction and post-myocardial. However, no reviews have comprehensively clarified the role of Tec kinases in the cardiovascular system. Therefore, this review summarizes research on the role of Tec kinases in cardiovascular disease, providing new insights into the prevention and treatment of cardiovascular disease.<\/jats:p>","DOI":"10.1038\/s41420-022-00927-4","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T07:03:01Z","timestamp":1647414181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Zeyu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-7398","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-899X","authenticated-orcid":false,"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3653-9801","authenticated-orcid":false,"given":"Naijin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"927_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.biochem.69.1.373","volume":"69","author":"SR Hubbard","year":"2000","unstructured":"Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem. 2000;69:373\u201398.","journal-title":"Annu Rev Biochem"},{"key":"927_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2443.1996.d01-234.x","volume":"1","author":"K Neet","year":"1996","unstructured":"Neet K, Hunter T. Vertebrate non-receptor protein-tyrosine kinase families. Genes Cells. 1996;1:147\u201369.","journal-title":"Genes Cells"},{"key":"927_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/385093a0","volume":"385","author":"AH Andreotti","year":"1997","unstructured":"Andreotti AH, Bunnell SC, Feng S, Berg LJ, Schreiber SL. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature 1997;385:93\u20137.","journal-title":"Nature"},{"key":"927_CR4","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","volume":"19","author":"DR Robinson","year":"2000","unstructured":"Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. 2000;19:5548\u201357.","journal-title":"Oncogene"},{"key":"927_CR5","first-page":"6","volume":"69","author":"H Mano","year":"1999","unstructured":"Mano H. The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings. Int J Hematol. 1999;69:6\u201312.","journal-title":"Int J Hematol"},{"key":"927_CR6","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1093\/emboj\/17.19.5638","volume":"17","author":"J Mao","year":"1998","unstructured":"Mao J, Xie W, Yuan H, Simon MI, Mano H, Wu D. Tec\/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12\/13. EMBO J. 1998;17:5638\u201346.","journal-title":"EMBO J"},{"key":"927_CR7","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.1074\/jbc.274.19.13577","volume":"274","author":"MG Tomlinson","year":"1999","unstructured":"Tomlinson MG, Kurosaki T, Berson AE, Fujii GH, Johnston JA, Bolen JB. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk. J Biol Chem. 1999;274:13577\u201385.","journal-title":"J Biol Chem"},{"key":"927_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0801-5","volume":"17","author":"Q Jiao","year":"2018","unstructured":"Jiao Q, Bi L, Ren Y, Song S, Wang Q, Wang YS. Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Mol Cancer. 2018;17:36.","journal-title":"Mol Cancer"},{"key":"927_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/13543784.2016.1182499","volume":"25","author":"P Norman","year":"2016","unstructured":"Norman P. Investigational Bruton\u2019s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2016;25:891\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"927_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.hoc.2017.04.009","volume":"31","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. Tyrosine kinase inhibitors in the treatment of eosinophilic neoplasms and systemic mastocytosis. Hematol Oncol Clin North Am. 2017;31:643\u201361.","journal-title":"Hematol Oncol Clin North Am"},{"key":"927_CR11","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1111\/jcmm.16618","volume":"25","author":"B Wu","year":"2021","unstructured":"Wu B, You S, Qian H, Wu S, Lu S, Zhang Y, et al. The role of SIRT2 in vascular-related and heart-related diseases: a review. J Cell Mol Med. 2021;25:6470\u20138.","journal-title":"J Cell Mol Med"},{"key":"927_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2478\/jtim-2020-0013","volume":"8","author":"P Wang","year":"2020","unstructured":"Wang P, Zhang N, Wu B, Wu S, Zhang Y, Sun Y. The role of mitochondria in vascular calcification. J Transl Int Med. 2020;8:80\u201390.","journal-title":"J Transl Int Med"},{"key":"927_CR13","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.7150\/ijbs.48437","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Qian H, Wu B, You S, Wu S, Lu S, et al. E3 Ubiquitin ligase NEDD4 family\u2011regulatory network in cardiovascular disease. Int J Biol Sci. 2020;16:2727\u201340.","journal-title":"Int J Biol Sci"},{"key":"927_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0092-8674(00)81022-3","volume":"85","author":"MA Lemmon","year":"1996","unstructured":"Lemmon MA, Ferguson KM, Schlessinger J. PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell. 1996;85:621\u20134.","journal-title":"Cell"},{"key":"927_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0014-5793(94)00783-7","volume":"350","author":"M Vihinen","year":"1994","unstructured":"Vihinen M, Nilsson L, Smith CI. Tec homology (TH) adjacent to the PH domain. FEBS Lett. 1994;350:263\u20135.","journal-title":"FEBS Lett"},{"key":"927_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/371168a0","volume":"371","author":"JE Harlan","year":"1994","unstructured":"Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature. 1994;371:168\u201370.","journal-title":"Nature"},{"key":"927_CR17","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1128\/MCB.19.2.1498","volume":"19","author":"J Debnath","year":"1999","unstructured":"Debnath J, Chamorro M, Czar MJ, Schaeffer EM, Lenardo MJ, Varmus HE, et al. rlk\/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol Cell Biol. 1999;19:1498\u2013507.","journal-title":"Mol Cell Biol"},{"key":"927_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1359-6101(99)00019-2","volume":"10","author":"H Mano","year":"1999","unstructured":"Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev. 1999;10:267\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"key":"927_CR19","doi-asserted-by":"publisher","first-page":"15480","DOI":"10.1074\/jbc.RA119.008318","volume":"294","author":"TCB Andersen","year":"2019","unstructured":"Andersen TCB, Kristiansen PE, Huszenicza Z, Johansson MU, Gopalakrishnan RP, Kjelstrup H, et al. The SH3 domains of the protein kinases ITK and LCK compete for adjacent sites on T cell-specific adapter protein. J Biol Chem. 2019;294:15480\u201394.","journal-title":"J Biol Chem"},{"key":"927_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1365-3083.1997.d01-447.x","volume":"45","author":"R Guinamard","year":"1997","unstructured":"Guinamard R, Fougereau M, Seckinger P. The SH3 domain of Bruton\u2019s tyrosine kinase interacts with Vav, Sam68 and EWS. Scand J Immunol. 1997;45:587\u201395.","journal-title":"Scand J Immunol"},{"key":"927_CR21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1349-7006.1996.tb03118.x","volume":"87","author":"Y Yamashita","year":"1996","unstructured":"Yamashita Y, Miyazato A, Ohya K, Ikeda U, Shimada K, Miura Y, et al. Deletion of Src homology 3 domain results in constitutive activation of Tec protein-tyrosine kinase. Jpn J Cancer Res. 1996;87:1106\u201310.","journal-title":"Jpn J Cancer Res"},{"key":"927_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0960-9822(95)00060-1","volume":"5","author":"BJ Mayer","year":"1995","unstructured":"Mayer BJ, Hirai H, Sakai R. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol. 1995;5:296\u2013305.","journal-title":"Curr Biol"},{"key":"927_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1074-7613(00)80189-2","volume":"12","author":"WC Yang","year":"2000","unstructured":"Yang WC, Collette Y, Nun\u00e8s JA, Olive D. Tec kinases: a family with multiple roles in immunity. Immunity. 2000;12:373\u201382.","journal-title":"Immunity"},{"key":"927_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1074-7613(00)80417-3","volume":"4","author":"H Park","year":"1996","unstructured":"Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity. 1996;4:515\u201325.","journal-title":"Immunity"},{"key":"927_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jmb.2007.08.060","volume":"373","author":"RE Joseph","year":"2007","unstructured":"Joseph RE, Fulton DB, Andreotti AH. Mechanism and functional significance of Itk autophosphorylation. J Mol Biol. 2007;373:1281\u201392.","journal-title":"J Mol Biol"},{"key":"927_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jmb.2009.06.023","volume":"391","author":"RE Joseph","year":"2009","unstructured":"Joseph RE, Severin A, Min L, Fulton DB, Andreotti AH. SH2-dependent autophosphorylation within the Tec family kinase Itk. J Mol Biol. 2009;391:164\u201377.","journal-title":"J Mol Biol"},{"key":"927_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1248\/bpb.25.718","volume":"25","author":"J Kashiwakura","year":"2002","unstructured":"Kashiwakura J, Suzuki N, Takeno M, Itoh S, Oku T, Sakane T, et al. Evidence of autophosphorylation in Txk: Y91 is an autophosphorylationsite. Biol Pharm Bull. 2002;25:718\u201321.","journal-title":"Biol Pharm Bull"},{"key":"927_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1034\/j.1600-065X.2003.00029.x","volume":"191","author":"JA Lucas","year":"2003","unstructured":"Lucas JA, Miller AT, Atherly LO, Berg LJ. The role of Tec family kinases in T cell development and function. Immunol Rev. 2003;191:119\u201338.","journal-title":"Immunol Rev"},{"key":"927_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1182\/blood.V91.3.940","volume":"91","author":"A Kitanaka","year":"1998","unstructured":"Kitanaka A, Mano H, Conley ME, Campana D. Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood. 1998;91:940\u20138.","journal-title":"Blood"},{"key":"927_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cmet.2008.03.013","volume":"7","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L. Bruton and Tec: new links in osteoimmunology. Cell Metab. 2008;7:283\u20135.","journal-title":"Cell Metab"},{"key":"927_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","volume":"132","author":"M Shinohara","year":"2008","unstructured":"Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell. 2008;132:794\u2013806.","journal-title":"Cell"},{"key":"927_CR32","first-page":"1781","volume":"5","author":"H Mano","year":"1990","unstructured":"Mano H, Ishikawa F, Nishida J, Hirai H, Takaku F. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene. 1990;5:1781\u20136.","journal-title":"Oncogene"},{"key":"927_CR33","doi-asserted-by":"publisher","first-page":"H713","DOI":"10.1152\/ajpheart.00273.2010","volume":"299","author":"MJ Zhang","year":"2010","unstructured":"Zhang MJ, Franklin S, Li Y, Wang S, Ru X, Mitchell-Jordan SA, et al. Stress signaling by Tec tyrosine kinase in the ischemic myocardium. Am J Physiol Heart Circ Physiol. 2010;299:H713\u201322.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"927_CR34","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1471-4159.2008.05275.x","volume":"105","author":"S zur Nedden","year":"2008","unstructured":"zur Nedden S, Tomaselli B, Baier-Bitterlich G. HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons. J Neurochem. 2008;105:1901\u201314.","journal-title":"J Neurochem"},{"key":"927_CR35","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.05-5129com","volume":"20","author":"YM Zhang","year":"2006","unstructured":"Zhang YM, Bo J, Taffet GE, Chang J, Shi J, Reddy AK, et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J. 2006;20:916\u201325.","journal-title":"FASEB J"},{"key":"927_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejmech.2018.03.062","volume":"151","author":"C Liang","year":"2018","unstructured":"Liang C, Tian D, Ren X, Ding S, Jia M, Xin M, et al. The development of Bruton\u2019s tyrosine kinase (BTK) inhibitors from 2012 to 2017: a mini-review. Eur J Med Chem. 2018;151:315\u201326.","journal-title":"Eur J Med Chem"},{"key":"927_CR37","first-page":"67","volume":"393","author":"OBJ Corneth","year":"2016","unstructured":"Corneth OBJ, Klein Wolterink RGJ, Hendriks RW. BTK signaling in B cell differentiation and autoimmunity. Curr Top Microbiol Immunol. 2016;393:67\u2013105.","journal-title":"Curr Top Microbiol Immunol"},{"key":"927_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1586\/1744666X.2016.1152888","volume":"12","author":"LJ Crofford","year":"2016","unstructured":"Crofford LJ, Nyhoff LE, Sheehan JH, Kendall PL. The role of Bruton\u2019s tyrosine kinase in autoimmunity and implications for therapy. Expert Rev Clin Immunol. 2016;12:763\u201373.","journal-title":"Expert Rev Clin Immunol"},{"key":"927_CR39","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41423-019-0270-9","volume":"17","author":"S Xia","year":"2020","unstructured":"Xia S, Liu X, Cao X, Xu S. T-cell expression of Bruton\u2019s tyrosine kinase promotes autoreactive T-cell activation and exacerbates aplastic anemia. Cell Mol Immunol. 2020;17:1042\u201352.","journal-title":"Cell Mol Immunol"},{"key":"927_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2141.2001.02905.x","volume":"114","author":"T Futatani","year":"2001","unstructured":"Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton\u2019s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol. 2001;114:141\u20139.","journal-title":"Br J Haematol"},{"key":"927_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.redox.2016.12.005","volume":"11","author":"S Kotla","year":"2017","unstructured":"Kotla S, Singh NK, Rao GN. ROS via BTK-p300-STAT1-PPAR\u03b3 signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation. Redox Biol. 2017;11:350\u201364.","journal-title":"Redox Biol"},{"key":"927_CR42","doi-asserted-by":"publisher","first-page":"9972413","DOI":"10.1155\/2021\/9972413","volume":"2021","author":"J Qiu","year":"2021","unstructured":"Qiu J, Fu Y, Chen Z, Zhang L, Li L, Liang D, et al. BTK promotes atherosclerosis by regulating oxidative stress, mitochondrial injury, and ER stress of macrophages. Oxid Med Cell Longev. 2021;2021:9972413.","journal-title":"Oxid Med Cell Longev"},{"key":"927_CR43","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res. 2018;122:1722\u201340.","journal-title":"Circ Res"},{"key":"927_CR44","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"927_CR45","doi-asserted-by":"publisher","first-page":"154215","DOI":"10.1016\/j.cyto.2017.11.009","volume":"122","author":"S Pfeiler","year":"2019","unstructured":"Pfeiler S, Winkels H, Kelm M, Gerdes N. IL-1 family cytokines in cardiovascular disease. Cytokine. 2019;122:154215.","journal-title":"Cytokine"},{"key":"927_CR46","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaci.2017.01.017","volume":"140","author":"X Liu","year":"2017","unstructured":"Liu X, Pichulik T, Wolz OO, Dang TM, Stutz A, Dillen C, et al. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase. J. Allergy Clin Immunol. 2017;140:1054\u20131067.e10.","journal-title":"J. Allergy Clin Immunol"},{"key":"927_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8360","volume":"6","author":"M Ito","year":"2015","unstructured":"Ito M, Shichita T, Okada M, Komine R, Noguchi Y, Yoshimura A, et al. Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun. 2015;6:7360.","journal-title":"Nat Commun"},{"key":"927_CR48","doi-asserted-by":"publisher","first-page":"630479","DOI":"10.3389\/fcell.2021.630479","volume":"9","author":"ANR Weber","year":"2021","unstructured":"Weber ANR. Targeting the NLRP3 Inflammasome via BTK. Front Cell Dev Biol. 2021;9:630479.","journal-title":"Front Cell Dev Biol"},{"key":"927_CR49","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood-2006-01-011817","volume":"108","author":"J Liu","year":"2006","unstructured":"Liu J, Fitzgerald ME, Berndt MC, Jackson CW, Gartner TK. Bruton tyrosine kinase is essential for botrocetin\/VWF-induced signaling and GPIb-dependent thrombus formation in vivo. Blood. 2006;108:2596\u2013603.","journal-title":"Blood"},{"key":"927_CR50","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.jacc.2015.03.573","volume":"65","author":"J Jamasbi","year":"2015","unstructured":"Jamasbi J, Megens RT, Bianchini M, M\u00fcnch G, Ungerer M, Faussner A, et al. Differential inhibition of human atherosclerotic plaque-induced platelet activation by dimeric GPVI-Fc and anti-GPVI antibodies: functional and imaging studies. J Am Coll Cardiol. 2015;65:2404\u201315.","journal-title":"J Am Coll Cardiol"},{"key":"927_CR51","first-page":"1663","volume":"95","author":"A Oda","year":"2000","unstructured":"Oda A, Ikeda Y, Ochs HD, Druker BJ, Ozaki K, Handa M, et al. Rapid tyrosine phosphorylation and activation of Bruton\u2019s tyrosine\/Tec kinases in platelets induced by collagen binding or CD32 cross-linking. Blood. 2000;95:1663\u201370.","journal-title":"Blood"},{"key":"927_CR52","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0960-9822(98)70471-3","volume":"8","author":"LS Quek","year":"1998","unstructured":"Quek LS, Bolen J, Watson SP. A role for Bruton\u2019s tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol. 1998;8:1137\u201340.","journal-title":"Curr Biol"},{"key":"927_CR53","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2017-09-808808","volume":"131","author":"K Busygina","year":"2018","unstructured":"Busygina K, Jamasbi J, Seiler T, Deckmyn H, Weber C, Brandl R, et al. Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans. Blood. 2018;131:2605\u201316.","journal-title":"Blood"},{"key":"927_CR54","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood-2018-04-841916","volume":"131","author":"JR Lindner","year":"2018","unstructured":"Lindner JR. Btk inhibitors in atherosclerosis. Blood. 2018;131:2601\u20132.","journal-title":"Blood"},{"key":"927_CR55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1055\/s-0039-1677744","volume":"119","author":"V Denzinger","year":"2019","unstructured":"Denzinger V, Busygina K, Jamasbi J, Pekrul I, Spannagl M, Weber C, et al. Optimizing platelet GPVI inhibition versus haemostatic impairment by the Btk inhibitors ibrutinib, acalabrutinib, ONO\/GS-4059, BGB-3111 and evobrutinib. Thromb Haemost. 2019;119:397\u2013406.","journal-title":"Thromb Haemost"},{"key":"927_CR56","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1055\/s-0039-1687877","volume":"119","author":"K Busygina","year":"2019","unstructured":"Busygina K, Denzinger V, Bernlochner I, Weber C, Lorenz R, Siess W. Btk Inhibitors as first oral atherothrombosis-selective antiplatelet drugs?. Thromb Haemost. 2019;119:1212\u201321.","journal-title":"Thromb Haemost"},{"key":"927_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MCC.0000000000000507","volume":"24","author":"KR Walley","year":"2018","unstructured":"Walley KR. Sepsis-induced myocardial dysfunction. Curr Opin Crit Care. 2018;24:292\u20139.","journal-title":"Curr Opin Crit Care"},{"key":"927_CR58","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","volume":"35","author":"A Rudiger","year":"2007","unstructured":"Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35:1599\u2013608.","journal-title":"Crit Care Med"},{"key":"927_CR59","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1073\/pnas.1119238109","volume":"109","author":"KG Lee","year":"2012","unstructured":"Lee KG, et al. Bruton\u2019s tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response. Proc Natl Acad Sci USA. 2012;109:5791\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"927_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00024382-200014020-00007","volume":"14","author":"KG Lee","year":"2000","unstructured":"Lee KG, Xu S, Kang ZH, Huo J, Huang M, Liu D, et al. Activation of NF-kappaB varies in different regions of the gastrointestinal tract during endotoxemia. Shock. 2000;14:118\u201322.","journal-title":"Shock"},{"key":"927_CR61","first-page":"658","volume":"55","author":"SF Liu","year":"1999","unstructured":"Liu SF, Ye X, Malik AB. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharm. 1999;55:658\u201367.","journal-title":"Mol Pharm"},{"key":"927_CR62","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.3389\/fimmu.2018.02996","volume":"9","author":"S Al Zoubi","year":"2018","unstructured":"Al Zoubi S, Chen J, Murphy C, Martin L, Chiazza F, Collotta D, et al. Linagliptin attenuates the cardiac dysfunction associated with experimental sepsis in mice with pre-existing type 2 diabetes by inhibiting NF-\u03baB. Front Immunol. 2018;9:2996.","journal-title":"Front Immunol"},{"key":"927_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1681\/ASN.2015060670","volume":"28","author":"J Chen","year":"2017","unstructured":"Chen J, Kieswich JE, Chiazza F, Moyes AJ, Gobbetti T, Purvis GS, et al. I\u03baB kinase inhibitor attenuates sepsis-induced cardiac dysfunction in CKD. J Am Soc Nephrol. 2017;28:94\u2013105.","journal-title":"J Am Soc Nephrol"},{"key":"927_CR64","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3389\/fimmu.2019.02129","volume":"10","author":"CE O\u2019Riordan","year":"2019","unstructured":"O\u2019Riordan CE, Purvis GSD, Collotta D, Chiazza F, Wissuwa B, Al Zoubi S, et al. Bruton\u2019s tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice. Front Immunol. 2019;10:2129.","journal-title":"Front Immunol"},{"key":"927_CR65","doi-asserted-by":"publisher","first-page":"e107639","DOI":"10.1371\/journal.pone.0107639","volume":"9","author":"W Zhang","year":"2014","unstructured":"Zhang W, Xu X, Kao R, Mele T, Kvietys P, Martin CM, et al. Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS ONE. 2014;9:e107639.","journal-title":"PLoS ONE"},{"key":"927_CR66","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1164\/rccm.201604-0892OC","volume":"196","author":"S Lee","year":"2017","unstructured":"Lee S, Nakahira K, Dalli J, Siempos II, Norris PC, Colas RA. et al. NLRP3 inflammasome deficiency protects against microbial sepsis via increased lipoxin B(4) synthesis. Am J Respir Crit Care Med. 2017;196:713\u201326.","journal-title":"Am J Respir Crit Care Med"},{"key":"927_CR67","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201308-1535OC","volume":"189","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe T, Demon D, Bogaert P, Vandendriessche B, Goethals A, Depuydt B, et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med. 2014;189:282\u201391.","journal-title":"Am J Respir Crit Care Med"},{"key":"927_CR68","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1073\/pnas.041611398","volume":"98","author":"BJ Pomerantz","year":"2001","unstructured":"Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci USA. 2001;98:2871\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"927_CR69","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","volume":"138","author":"C Yao","year":"2018","unstructured":"Yao C, Veleva T, Scott L Jr, Cao S, Li L, Chen G, et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation. 2018;138:2227\u201342.","journal-title":"Circulation"},{"key":"927_CR70","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.4049\/jimmunol.1002813","volume":"186","author":"M Gottar-Guillier","year":"2011","unstructured":"Gottar-Guillier M, Dodeller F, Huesken D, Iourgenko V, Mickanin C, Labow M, et al. The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner. J Immunol. 2011;186:6014\u201323.","journal-title":"J Immunol"},{"key":"927_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jso.20983","volume":"97","author":"L Guo","year":"2008","unstructured":"Guo L, Guo Y, Xiao S. Expression of Etk\/Bmx tyrosine kinase in intrahepatic cholangiocarcinoma. J Surg Oncol. 2008;97:428\u201332.","journal-title":"J Surg Oncol"},{"key":"927_CR72","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/01.CIR.96.6.1729","volume":"96","author":"N Ekman","year":"1997","unstructured":"Ekman N, Lymboussaki A, V\u00e4strik I, Sarvas K, Kaipainen A, Alitalo K. Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries. Circulation. 1997;96:1729\u201332.","journal-title":"Circulation"},{"key":"927_CR73","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.186577","volume":"103","author":"SA Mitchell-Jordan","year":"2008","unstructured":"Mitchell-Jordan SA, Holopainen T, Ren S, Wang S, Warburton S, Zhang MJ, et al. Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy. Circ Res. 2008;103:1359\u201362.","journal-title":"Circ Res"},{"key":"927_CR74","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","volume":"122","author":"M Bry","year":"2010","unstructured":"Bry M, Kivel\u00e4 R, Holopainen T, Anisimov A, Tammela T, Soronen J, et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation. 2010;122:1725\u201333.","journal-title":"Circulation"},{"key":"927_CR75","doi-asserted-by":"publisher","first-page":"13063","DOI":"10.1073\/pnas.1517810112","volume":"112","author":"T Holopainen","year":"2015","unstructured":"Holopainen T, R\u00e4s\u00e4nen M, Anisimov A, Tuomainen T, Zheng W, Tvorogov D, et al. Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling. Proc Natl Acad Sci USA. 2015;112:13063\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"927_CR76","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, et al. Celastrol Attenuates angiotensin II-induced cardiac remodeling by targeting STAT3. Circ Res. 2020;126:1007\u201323.","journal-title":"Circ Res"},{"key":"927_CR77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fcvm.2019.00050","volume":"6","author":"FA Zouein","year":"2019","unstructured":"Zouein FA, Booz GW, Altara R. STAT3 and endothelial cell-cardiomyocyte dialog in cardiac remodeling. Front Cardiovasc Med. 2019;6:50.","journal-title":"Front Cardiovasc Med"},{"key":"927_CR78","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376.","journal-title":"Nat Med"},{"key":"927_CR79","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jcmm.14663","volume":"24","author":"T Liu","year":"2020","unstructured":"Liu T, Li Y, Su H, Zhang H, Jones D, Zhou HJ, et al. Nuclear localization of the tyrosine kinase BMX mediates VEGFR2 expression. J Cell Mol Med. 2020;24:126\u201338.","journal-title":"J Cell Mol Med"},{"key":"927_CR80","first-page":"2344","volume":"116","author":"Y He","year":"2006","unstructured":"He Y, Luo Y, Tang S, Rajantie I, Salven P, Heil M, et al. Critical function of Bmx\/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Investig. 2006;116:2344\u201355.","journal-title":"J Clin Investig"},{"key":"927_CR81","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1128\/MCB.22.21.7512-7523.2002","volume":"22","author":"S Pan","year":"2002","unstructured":"Pan S, An P, Zhang R, He X, Yin G, Min W. Etk\/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol Cell Biol. 2002;22:7512\u201323.","journal-title":"Mol Cell Biol"},{"key":"927_CR82","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00041433-200212000-00009","volume":"13","author":"SB Freedman","year":"2002","unstructured":"Freedman SB. Clinical trials of gene therapy for atherosclerotic cardiovascular disease. Curr Opin Lipido. 2002;13:653\u201361.","journal-title":"Curr Opin Lipido"},{"key":"927_CR83","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-11-1070","volume":"72","author":"T Holopainen","year":"2012","unstructured":"Holopainen T, L\u00f3pez-Alpuche V, Zheng W, Heljasvaara R, Jones D, He Y, et al. Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. Cancer Res. 2012;72:3512\u201321.","journal-title":"Cancer Res"},{"key":"927_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/01.RES.88.1.59","volume":"88","author":"P Ping","year":"2001","unstructured":"Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res. 2001;88:59\u201362.","journal-title":"Circ Res"},{"key":"927_CR85","doi-asserted-by":"publisher","first-page":"H2364","DOI":"10.1152\/ajpheart.00416.2004","volume":"287","author":"J Zhang","year":"2004","unstructured":"Zhang J, Ping P, Wang GW, Lu M, Pantaleon D, Tang XL, et al. Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotection. Am J Physiol Heart Circ Physiol. 2004;287:H2364\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"927_CR86","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.115.020143","volume":"133","author":"O Henri","year":"2016","unstructured":"Henri O, Pouehe C, Houssari M, Galas L, Nicol L, Edwards-L\u00e9vy F, et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation. 2016;133:1484\u201397. discussion 1497.","journal-title":"Circulation"},{"key":"927_CR87","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1161\/ATVBAHA.110.214999","volume":"30","author":"D Jones","year":"2010","unstructured":"Jones D, Xu Z, Zhang H, He Y, Kluger MS, Chen H, et al. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis. Arterioscler Thromb Vasc Biol. 2010;30:2553\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"927_CR88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","volume":"228","author":"JA Readinger","year":"2009","unstructured":"Readinger JA, Mueller KL, Venegas AM, Horai R, Schwartzberg PL. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk. Immunol Rev. 2009;228:93\u2013114.","journal-title":"Immunol Rev"},{"key":"927_CR89","doi-asserted-by":"publisher","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","volume":"2","author":"AH Andreotti","year":"2010","unstructured":"Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ. T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol. 2010;2:a002287.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"927_CR90","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.4049\/jimmunol.178.6.3575","volume":"178","author":"D Khurana","year":"2007","unstructured":"Khurana D, Arneson LN, Schoon RA, Dick CJ, Leibson PJ. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk. J Immunol. 2007;178:3575\u201382.","journal-title":"J Immunol"},{"key":"927_CR91","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaci.2005.12.1330","volume":"117","author":"TJ Ferrara","year":"2006","unstructured":"Ferrara TJ, Mueller C, Sahu N, Ben-Jebria A, August A. Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase. J Allergy Clin Immunol. 2006;117:780\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"927_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000067589","volume":"129","author":"Y Matsumoto","year":"2002","unstructured":"Matsumoto Y, Oshida T, Obayashi I, Imai Y, Matsui K, Yoshida NL, et al. Identification of highly expressed genes in peripheral blood T cells from patients with atopic dermatitis. Int Arch Allergy Immunol. 2002;129:327\u201340.","journal-title":"Int Arch Allergy Immunol"},{"key":"927_CR93","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jaci.2015.08.056","volume":"137","author":"W Huang","year":"2016","unstructured":"Huang W, Morales JL, Gazivoda VP, August A. Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide. J Allergy Clin Immunol. 2016;137:1197\u2013205.","journal-title":"J Allergy Clin Immunol"},{"key":"927_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0754-9","volume":"19","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32.","journal-title":"Cancer Cell Int"},{"key":"927_CR95","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/cid\/ciy942","volume":"68","author":"L Youssefian","year":"2019","unstructured":"Youssefian L, Vahidnezhad H, Yousefi M, Saeidian AH, Azizpour A, Touati A, et al. Inherited interleukin 2-inducible T-cell (ITK) kinase deficiency in siblings with epidermodysplasia verruciformis and Hodgkin lymphoma. Clin Infect Dis. 2019;68:1938\u201341.","journal-title":"Clin Infect Dis"},{"key":"927_CR96","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ejps.2012.07.013","volume":"47","author":"M Kaur","year":"2012","unstructured":"Kaur M, Bahia MS, Silakari O. Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions. Eur J Pharm Sci. 2012;47:574\u201388.","journal-title":"Eur J Pharm Sci"},{"key":"927_CR97","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.4049\/jimmunol.1501828","volume":"195","author":"HS Cho","year":"2015","unstructured":"Cho HS, Shin HM, Haberstock-Debic H, Xing Y, Owens TD, Funk JO, et al. A small molecule inhibitor of ITK and RLK impairs Th1 differentiation and prevents colitis disease progression. J Immunol. 2015;195:4822\u201331.","journal-title":"J Immunol"},{"key":"927_CR98","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1084\/jem.190.8.1147","volume":"190","author":"J Kashiwakura","year":"1999","unstructured":"Kashiwakura J, Suzuki N, Nagafuchi H, Takeno M, Takeba Y, Shimoyama Y, et al. Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes. J Exp Med. 1999;190:1147\u201354.","journal-title":"J Exp Med"},{"key":"927_CR99","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/08830180701690835","volume":"26","author":"S Mihara","year":"2007","unstructured":"Mihara S, Suzuki N. Role of Txk, a member of the Tec family of tyrosine kinases, in immune-inflammatory diseases. Int Rev Immunol. 2007;26:333\u201348.","journal-title":"Int Rev Immunol"},{"key":"927_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3121\/cmr.4.2.147","volume":"4","author":"N Suzuki","year":"2006","unstructured":"Suzuki N, Nara K, Suzuki T. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet\u2019s disease. Clin Med Res. 2006;4:147\u201351.","journal-title":"Clin Med Res"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00927-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:15:49Z","timestamp":1669302949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-00927-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-00927-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}